CHRU de Brest
Brest, 29609, France
NCT Number: NCT03360162
The use of ultrasonography in detecting giant cell arteritis ( GCA) is emerging. Currently, temporal biopsy is the gold standard to diagnose GCA but studies have shown the interest to use B mode ultrasonography. However, until now, the study of velocities in GCA have not been yet performed.
Looking for future studies?
Notify Me55 year and older
All sexes
Observational
Brest, 29609, France
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: 2 months
velocimetric temporal arterial study in giant arteritis
Time frame: 2 months
presence or absence of the halo sign in giant arteritis patients
University Hospital, Brest
Other
Acronym: VELHOR
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04010097
Arteritis, Autoimmune Diseases
Avignon, France
View Trial DetailsNCT04142515
Arteritis, Autoimmune Diseases
Nîmes, France
View Trial DetailsNCT06244069
Arteritis, Autoimmune Diseases
View Trial DetailsNCT03841734
Arteritis, Arteritis, Giant Cell
Cannes, France
View Trial Details